Peritumoral Lidocaine Injection in BREast cancer: impact on Time TO recurrence and survival
Brief Description
A prospective randomized phase III open-label multicenter study to evaluate the effect of preoperative peritumoral injection of local anesthetic lidocaine on recurrence risk and survival in early breast cancer.
Principal Investigator
Prof. Dr. med. Maggie Banys-Paluchowski
- Vice-Chairwoman of EUBREAST e.V.
- Head of Breast Cancer Center
- Head of Center for Familial Breast and Ovarian Cancer
- University Hospital Schleswig-Holstein Campus Lübeck
